Navigation Links
Pharma, Biotech Clinical Trial Leaders to Convene for 3rd Annual DrugDev Summit to Promote Collaboration, Technology Innovation, Engaged Sites, and More Informed Patients
Date:9/14/2017

DrugDev, a QuintilesIMS company, will gather the most innovative minds in pharma and biotech at the third annual DrugDev Summit, November 7-8, 2017 in Philadelphia, PA. The DrugDev Summit is a two-day collaborative conference that brings together the world’s most progressive clinical research leaders for best practice case studies, keynote presentations, lively breakout sessions, hands-on training, and previews of new DrugDev technology-based solutions.

Featuring a client-driven agenda and highlighted by inspiring industry keynotes (announcements to come soon), last year’s Summit welcomed expert speakers from host company Merck, Janssen, Pfizer, Novartis, Eli Lilly, ICON, Boehringer-Ingelheim, Incyte, Alkermes, BioMarin, Chesapeake IRB, Radiant Research, and Emerson Clinical Research Institute. Register for the 2017 DrugDev Summit here.

“The 2016 DrugDev Summit was a very engaging event,” said Dawn Furey, Executive Director/Head, Global Operations, at Merck. “I didn’t think I would stay for the entire two days given my competing priorities, but I couldn’t step away. It was great.”

DrugDev expects more than 125 clinical leaders to attend this year’s Summit, which promotes three pillars of clinical research optimization – collaboration, standardization, and a beautiful technology experience – to transform the quality, transparency and efficiency of clinical trials. Summit participants gain actionable advice and inspiration from sponsors, sites and patients as they network in an organized yet congenial setting. The invitation-only event is complimentary for all sponsors, CROs and sites using DrugDev technology on nearly 2,000 clinical programs.

DrugDev President and CEO Ibs Mahmood said, “Imagine the best minds in pharma and biotech gathering together, all fearless in their dedication to changing everything to speed the delivery of many more new treatments to millions of patients, and there you have the DrugDev Summit. I’m always awed by the brilliant insights and the interactions among professionals who just want to get it done for patients. I expect this year to be especially exciting as customers share their experiences standardizing on the DrugDev Spark™ unified suite across entire, massive clinical programs, and I’m very much looking forward to seeing what they can accomplish next.”

summit(at)drugdev.com with questions or for more information.

About DrugDev

DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14687535.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Biotech Stocks Under Scanner -- Biostage, Keryx Biopharma, Kite Pharma, and ZIOPHARM Oncology
2. Research Reports Initiation on Biotech Stocks -- Tesaro, Alnylam Pharma, Corbus Pharma, and Inovio Pharma
3. Research Reports Coverage on Biotech Stocks -- Agenus, Intrexon, Progenics Pharma, and Concordia
4. Biotech Stocks on Investors Radar -- Portola Pharma, OvaScience, Ocera Therapeutics, and Ocular Therapeutix
5. Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma
6. Research Reports Initiation on Biotech Stocks -- Sangamo, Eyegate Pharma, Synthetic Biologics, and Regulus
7. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, will present a clinical abstract on Allogeneic Adipose Stem Cell Bio-Distribution at the Veterinary Orthopedic
8. Global Licensing Partnering Report: Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016 - Research and Markets
9. Technical Reports on Biotech Stocks -- ZIOPHARM Oncology, Aurinia Pharma, Arena Pharma, and Marinus Pharma
10. Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead Pharma, Pacific Biosciences of California, and Conatus Pharma
11. VetStem Biopharma, Inc., Announces the Opening of its GMP Cell Therapy Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... ... August 08, 2018 , ... InTouchMD , the ... announced that they will be exhibiting at Biotech Week Boston , September 4th ... showcasing its Pulse platform, healthcare’s most powerful all in one marketing solution. ...
(Date:8/9/2018)... MAss. (PRWEB) , ... August 09, 2018 , ... ... group of architectural, engineering, and construction (AEC) experts with building owners and managers ... England. The fourth-annual Create + Construct symposium comes to Boston for the first ...
(Date:7/31/2018)... ... July 31, 2018 , ... Leading regenerative veterinary medicine company, ... and using adipose tissue-derived stem cells to treat or prevent inflammation at the ... covers Canada specifically, VetStem has been issued similar patents that cover the United ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne Afaganis, ... a biofield energy treated nutraceutical to improve anti-inflammatory and immune function responses. , ... in the preclinical research, were significantly reduced. Results are as follows:, ...
Breaking Biology Technology:
(Date:8/2/2018)... ... August 02, 2018 , ... ... in our Austin office, has been named Practice Group Chair for the Pharmaceuticals ... to help continue growing Dickinson Wright’s healthcare and life sciences initiatives, and appreciate ...
(Date:8/1/2018)... ... August 01, 2018 , ... RURO, Inc., a company ... 7.1. Limfinity® is the software framework that all of RURO’s products are built ... current users and the future of RURO’s laboratory software portfolio. , To accommodate ...
(Date:7/31/2018)... DIEGO (PRWEB) , ... July 31, 2018 , ... ACEA ... analysis. The company has just introduced the xCELLigence RTCA S16, which the ... and monitored via an external computer, the S16can be placed in any standard CO2 ...
Breaking Biology News(10 mins):